Leica Bond Rx Controller
Award Notice Posted
- Solicitation number
- 75N91026P00006
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N91026P00006
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- PSC
- Q515 Medical- Pathology
- Place of performance
- Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute (NCI), operating under the Department of Health and Human Services Office of the Assistant Secretary for Administration, awarded a firm fixed price purchase order (Contract No. 75N91026P00006) to Ferox LLC on January 29, 2026, for $30,500.00 to supply a Leica Bond Rx Controller for an automated immunohistochemistry stainer. The contract includes a one-year warranty and recommended preventative maintenance services with an included preventative maintenance kit, following the instrument's relocation to the NCI facility. The Bond Rx Controller will be utilized for validation of clinical immunohistochemistry target markers supporting diagnostic applications and enrollment into NIH clinical trials, with a specific focus on rare tumor identification and the development of therapeutic mechanisms for patients undergoing treatment.
Notice text
This is a Firm Fixed Price Purchase Order. The National Cancer Institute (NCI) awarded a purchase order to Ferox LLC to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.
Awarded contract 75N91026P00006 to FEROX LLC for 30500.00 on 2026-01-29.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Acquisition of a Leica Bond Rx Controller | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Maintenance Agreement, Leica BOND RX Processing Module | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity